Cetrorelix Acetate is a synthetic GnRH antagonist that immediately suppresses LH and FSH without an initial flare, used to prevent premature ovulation during controlled ovarian stimulation in assisted reproduction. Simson Pharma's Cetrorelix Acetate reference standard and impurities support QC for this injectable reproductive-medicine peptide.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cetrorelix acetate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.